Skip to content

Effects of Dexmedetomidine on Postoperative Cognitive Dysfunction During One-lung Ventilation in Elder Patients

Effects of Dexmedetomidine on Postoperative Cognitive Dysfunction During One-lung Ventilation in Elder Patients -a Single-center, Randomized ,Double-blinded and Controlled Trial

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02134093
Enrollment
120
Registered
2014-05-08
Start date
2014-07-31
Completion date
2015-12-31
Last updated
2014-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Confusion

Brief summary

This study is to explore the effects of dexmedetomidine on postoperative cognitive dysfunction during one-lung ventilation in elder patients.

Interventions

DRUGInduction of anesthesia,midazolam ,sufentanil,etomidate and rocuronium

Anesthesia induction:midazolam (0.03\ 0.05 mg/kg), sufentanil(0. 5\ 0.8 μg/kg), etomidate ( 0.2\ 0.6mg/kg) and rocuronium(0.6mg/kg)

DRUGDexmedetomidine

Continuous pump infusion dexmedetomidine at 0.5μg/kg (low dose group)or 1μg/kg (high dose group)for 15 minutes before anesthesia induction,then followed by a continuous pump infusion at 0.2 μg/kg/h(low dose group)or 0.4μg/kg/h(high dose group) until the end of surgery.

DRUGNormal saline

Continuous pump infusion normal saline with identical volume of dexmedetomidine.

DRUGMaintenance of anesthesia , propofol, remifentanil,vecuronium

Continuous infusion of propofol (3\ 6 mg/kg/h), remifentanil (0.05\ 0.3 μg/kg/min)is required to maintain Entropy within 40\ 60,Mean Arterial Blood Pressure more than 20% of baseline level , Oxygen Saturation more than 90% , airway pressure less than 40 cm H2O, intermittent injection vecuronium (0.05\ 0.1mg/kg) as needed to maintain muscle relaxation.

Sponsors

Tang-Du Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
55 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Written informed consent. * Ongoing one-lung ventilation surgery. * American Society of Anesthesiologists class I to III. * Aged between 55 and 75 years old. * Body Mass Index between 18 and 25 kg/m2.

Exclusion criteria

* Systolic blood pressure more than 180 mmHg or lower than 90 mmHg,diastolic blood pressure more than 110 mmHg or lower than 60 mmHg. * Serious heart,liver,kidney, pulmonary, and endocrine disease or serious infection. * Suspected or confirmed difficult airway. * History of abnormal anesthesia. * Suspected of malignant hyperthermia. * Use of sedative and antidepressant drug or serious alcoholism * Mini-mental State Examination less than 17. * Highest academic degree below grade 6 in primary schools * Patients inability to exchange with serious visual and hearing impairment or mental disability. * History of shock. * Carotid artery stenosis and central nervous system disease such as stroke, epilepsy. * Allergic to investigational products or with other contraindication. * Participated in other study within 30 days .

Design outcomes

Primary

MeasureTime frameDescription
The change in memoryone day before operation, first day after operationThe change in memory will be evaluated by Controlled Oral Word Association Test ,Semantic Fluency test
Cognitive functionone day before operation, first day after operationCognitive function will be evaluated by Mini-mentalStateExamination,Digit-Symbol Substitution Test ,Trail Making Test
Postoperative anxietyone day before operation, first day after operationSelf-evaluation of Depression Symptoms form,Self-Rating Anxiety Scale,Visual analog scales

Secondary

MeasureTime frame
Duration of one lung ventilationAt the beginning of one lung ventilation,at the end of one lung ventilation,an expected average of 3 hours
The total dose of anaesthetic drugsAt the beginning of surgery,at the end of surgery,up to 24 hours
The total dose of analgesic drugsDuring perioperative period,up to 7 days
Heart rateAt the moment of entering operating room ,the moment of intubation,prior to one lung ventilation,10 minutes,30 minutes afer one lung ventilation,the end of operation and the moment of leaving the operating room
Oxygen saturationAt the moment of entering operating room ,the moment of intubation,prior to one lung ventilation,10 minutes,30 minutes afer one lung ventilation,the end of operation and the moment of leaving the operating room
End-tidal carbon dioxideAt the moment of entering operating room ,the moment of intubation,prior to one lung ventilation,10 minutes,30 minutes afer one lung ventilation,the end of operation and the moment of leaving the operating room
Operation durationAt the beginning of surgery,at the end of surgery,up to 24 hours
Blood pressureAt the moment of entering operating room ,the moment of intubation,prior to one lung ventilation,10 minutes,30 minutes afer one lung ventilation,the end of operation and the moment of leaving the operating room
Bleeding volumeAt the beginning of operation,at the end of operation,up to 24 hours
Total volume of fluidAt the beginning of operation,at the end of operation,up to 24 hours

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026